Two Americans Win Nobel Prize for Contributions to Cycles of Boom-Bust The prestigious prize, which has never been awarded in economics before, honored Hall and Woodford for their pioneering contributions to understanding how individuals make decisions regarding purchases and prices. Their focus on individual action has become fundamental to the “new Keynesian” style of economics that seeks to smooth out economic fluctuations. This year's Nobel is particularly significant because it comes during an unprecedented time when the world faces challenges. The pandemic has led millions of people to lose jobs while supply shocks have driven up living costs.

These events highlight the need for governments and banks to manage these economic flows effectively to avoid prolonged high unemployment periods or devastating inflationary peaks.

John Hassler, president of the Nobel Prize Committee for Economics, has emphasized that reducing the amplitude of these economic flows and limiting associated risks is crucial for maintaining economic equilibrium. He noted that this prize is not among the first five but rather a 'memory' award honoring Alfred Nobel.

Hall's and Woodford's contributions have also found practical applications in the medical clinical field. Researchers are using optogenetics, developed by Karl Deisseroth and his colleagues, to restore vision in individuals with visual impairments.

Optogenetics allows scientists to map brain circuits more precisely for better understanding of neurological diseases and psychological disorders. Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the Nobel Prize for their significant research in optogenetics. The discovery of channelrhodopsin, an algae used to control cellular activity with light, has opened up new techniques for mapping brain circuits. Peter Svenningsson, president of the Nobel Committee for Physics or Medicine, highlighted the potential of optogenetics to illuminate neural circuits and bring them into focus in cats.

This technique has already proven valuable in understanding nervous cells and circuits in mammals, leading to improved comprehension of neurological and psychiatric diseases. Three men will participate in the £900,000 ($12 million in euros) prize, further strengthening their bond with neuroscience and clinical medicine research. Their ongoing studies inspire global researchers, pushing them forward.